Publications by authors named "Juan Juaneda"
Objective: Hepatitis B (HB) is a preventable disease and a public health challenge due to its high morbidity and mortality. This study was conducted within the framework of the World Health Organization's strategy, which includes establishing prophylactic measures to prevent vertical transmission. The aim was to assess the degree of implementation of HB preventive measures to avoid vertical transmission in newborns in Spain.
View Article and Find Full Text PDFPublic funding of vaccines may enhance vaccination rates, co-administration, and timeliness. The impacts of including the serogroup B meningococcus vaccine (MenB) into the national immunisation schedule on vaccination rates, co-administration rates, and timeliness were assessed using a population-based pre-funding (2022) and post-funding (2023) study design. MenB vaccination rates improved after funding and were in line with previously funded vaccines.
View Article and Find Full Text PDFArticle Synopsis
- Respiratory syncytial virus (RSV) is a major cause of illness and hospitalization in young children, particularly those under 1 year old.
- In the Valencian Community of Spain, a new monoclonal antibody called nirsevimab was introduced for high-risk children and those under 6 months as a preventive measure for the 2023-2024 RSV season.
- Preliminary results indicate that the immunization campaign achieved 88.5% coverage, with immunized children showing a threefold reduction in RSV incidence and lower hospitalization rates for respiratory infections compared to those who were not immunized.